Drug Shortage Report for APO-RIVASTIGMINE

Last updated on 2018-03-27 History
Report ID 17322
Drug Identification Number 02336758
Brand name APO-RIVASTIGMINE
Common or Proper name RIVASTIGMINE
Company Name APOTEX INC
Active Ingredient(s) RIVASTIGMINE
Strength(s) 6MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BTL
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-09-18
Actual start date 2017-08-28
Estimated end date 2018-03-30
Actual end date 2018-03-26
Shortage status Resolved
Updated date 2018-03-27
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2018-03-27 English Compare
v17 2018-03-26 French Compare
v16 2018-03-26 English Compare
v15 2018-02-13 French Compare
v14 2018-02-13 English Compare
v13 2018-02-12 French Compare
v12 2018-02-12 English Compare
v11 2018-01-16 French Compare
v10 2018-01-16 English Compare
v9 2017-11-20 French Compare
v8 2017-11-20 English Compare
v7 2017-11-20 English Compare
v6 2017-09-25 French Compare
v5 2017-09-25 English Compare
v4 2017-08-31 French Compare
v3 2017-08-31 English Compare
v2 2017-07-26 French Compare
v1 2017-07-26 English Compare